GE HEALTHCARE TECH.INC. Capital Reinvestment Ratio

Latest as of March 2026: 0.61x

GE HEALTHCARE TECH.INC. capital reinvestment ratio. GE HEALTHCARE TECH.INC. (L0T) has a Capital Reinvestment Ratio of 0.61x as of March 2026, meaning it reinvests 1% of its operating cash flow (€290.00 Million) in capital expenditures (€178.00 Million). See L0T FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.61x
Capex / Operating Cash Flow

Operating Cash Flow

€290.00 Million
EUR

Capital Expenditures

€178.00 Million
EUR

Data as of

Mar 2026
Most recent filing

Capital Reinvestment Ratio of GE HEALTHCARE TECH.INC. (2022–2025)

Capital reinvestment ratio of GE HEALTHCARE TECH.INC. from 2022 to 2025. This chart tracks GE HEALTHCARE TECH.INC.'s Capital Reinvestment Ratio across 4 annual periods. See L0T FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

GE HEALTHCARE TECH.INC. Capital Reinvestment Ratio by Year (2022–2025)

GE HEALTHCARE TECH.INC. capital reinvestment ratio by year from 2022 to 2025. For the full cash flow conversion analysis, see GE HEALTHCARE TECH.INC. cash flow conversion.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.24x €1.99 Billion €482.00 Million ▲ +18.0%
2024 0.21x €1.95 Billion €401.00 Million ▲ +11.6%
2023 0.18x €2.10 Billion €387.00 Million ▲ +25.6%
2022 0.15x €2.11 Billion €310.00 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow